Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
Title: Evidence for Results for Adverse event free and hypertension control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan
Variable in role of population: the study group
Variable in role of exposure: GroupAssignment: Quadpill vs. Candesartan
Variable in role of outcome: Adverse event free and hypertension control at 12 weeks
Statistic: odds ratio (coded as: STATO:0000182 from https://fevir.net/sevco) 0.83